0001055726-19-000004.txt : 20190104 0001055726-19-000004.hdr.sgml : 20190104 20190104163319 ACCESSION NUMBER: 0001055726-19-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190103 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zoth Lota S. CENTRAL INDEX KEY: 0001278219 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 19510531 MAIL ADDRESS: STREET 1: 334 CR 692 CITY: BUFFALO GAP STATE: TX ZIP: 79508 FORMER NAME: FORMER CONFORMED NAME: ZOTH LOTA S DATE OF NAME CHANGE: 20040130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330024450 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_154663758186763.xml FORM 4 X0306 4 2019-01-03 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001278219 Zoth Lota S. 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 1 0 0 0 Common Stock Option 4.28 2019-01-03 4 A 0 20000 0 A 2029-01-03 Common Stock 20000.0 20000 D Restricted Stock Unit 2019-01-03 4 A 0 12270 0 A Common Stock 12270.0 12270 D This grant was made pursuant to the issuer's non-employee director compensation policy. The vesting schedule for the 20,000 options is as follows: 5,000 shares vested on January 3, 2019; 5,000 shares will vest on January 3, 2020; 5,000 shares will vest on January 3, 2021; 5,000 shares will vest on January 3, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,270 restricted stock units is as follows: 4,090 shares will vest on January 3, 2020; 4,090 shares will vest on January 3, 2021; 4,090 shares will vest on January 3, 2022. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both. /s/ Lota Zoth 2019-01-04